Intercept Pharmaceuticals
ICPT
#6664
Rank
โ‚น74.25 B
Marketcap
โ‚น1,775
Share price
0.00%
Change (1 day)
-2.91%
Change (1 year)

Earnings for Intercept Pharmaceuticals (ICPT)

Earnings in 2023 (TTM): -โ‚น4.78 Billion

According to Intercept Pharmaceuticals 's latest financial reports the company's current earnings are โ‚น0.31 Billion. In 2022 the company made an earning of -โ‚น14.88 Billion a decrease over its 2021 earnings that were of -โ‚น8.55 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Intercept Pharmaceuticals from 2012 to 2023

Annual earnings

Year Earnings Change
2023 (TTM) -โ‚น4.78 Billion-67.88%
2022 -โ‚น14.88 Billion74.17%
2021 -โ‚น8.55 Billion-66.74%
2020 -โ‚น25.69 Billion-20.25%
2019 -โ‚น32.21 Billion11.46%
2018 -โ‚น28.9 Billion-14.19%
2017 -โ‚น33.68 Billion-12.71%
2016 -โ‚น38.58 Billion82.32%
2015 -โ‚น21.16 Billion-23.21%
2014 -โ‚น27.56 Billion334.95%
2013 -โ‚น6.34 Billion60.48%
2012 -โ‚น3.95 Billion

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Eli Lilly
LLY
โ‚น3.248 T-60,036.56%๐Ÿ‡บ๐Ÿ‡ธ USA
Gilead Sciences
GILD
-โ‚น236.69 Billion 4,266.49%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
โ‚น1.058 T-19,634.56%๐Ÿ‡บ๐Ÿ‡ธ USA
MediciNova
MNOV
-โ‚น1.01 Billion-81.47%๐Ÿ‡บ๐Ÿ‡ธ USA